Barrientos, Jacqueline C.
Ayed, Ayed O.
Cha, Agnes
Du, Senxi
Fang, Bruno
Hall, Ryan
Marks, Stanley M.
Peng, Eileen
Rhodes, Joanna M.
Ryan, Kellie
Winters, Sharon B.
Yeung, Percy L.
Hou, Jing-Zhou http://orcid.org/0000-0001-8916-0921
Funding for this research was provided by:
AstraZeneca
Article History
Accepted: 3 August 2023
First Online: 20 September 2023
Declarations
:
: This study was sponsored by AstraZeneca. Medical writing and editorial support was provided by Claire Jarvis, PhD, and Maria Ali, PhD, of Peloton Advantage, LLC (Parsippany, NJ, USA), an OPEN Health company, and funded by AstraZeneca.
: Jacqueline C. Barrientos has received research support from Oncternal, VelosBio, AstraZeneca, and Pharmacyclics/AbbVie and has served on advisory boards for BeiGene, Pharmacyclics/AbbVie, TG Therapeutics, and MEI Pharma. Ayed O. Ayed has served on an advisory board for AstraZeneca. Agnes Cha has received a research grant (paid to institution) from AstraZeneca. Senxi Du, Bruno Fang, Ryan Hall, Stanley M. Marks, Eileen Peng, Sharon B. Winters, and Percy L. Yeung have no disclosures to report. Joanna M. Rhodes has received research support from Oncternal, VelosBio, Pharmacyclics/AbbVie, and LOXO Oncology and has served as a consultant for BeiGene, Pharmacyclics/AbbVie, TG Therapeutics, MorphoSys, Verastem, ADC Therapeutics, Genentech, SeaGen, GenMab, Janssen, Epizyme, and AstraZeneca. Kellie Ryan is an employee of AstraZeneca. Jing-Zhou Hou has received a research grant (paid to institution) from AstraZeneca.
: The study protocol was exempt from ethical review by the Western Institutional Review Board (WA, USA) prior to starting data collection. This observational study was performed in accordance with ethical principles that are consistent with the Declaration of Helsinki, the International Conference on Harmonisation’s Guidelines for Good Clinical Practice, the Guidelines for Good Pharmacoepidemiology Practices and applicable legislation on noninterventional studies and/or observational studies.
: Not applicable.
: Not applicable.
: Data underlying the findings described in this manuscript may be obtained in accordance with AstraZeneca’s data sharing policy described at . Data for studies directly listed on Vivli can be requested through Vivli at . Data for studies not listed on Vivli could be requested through Vivli at . AstraZeneca Vivli member page is also available outlining further details: .
: Not applicable.
: SMM and KR designed the study. JCB, AC, BF, RH, SMM, and JMR served as study investigators. AC, SD, RH, SMM, JMR, SBW, and PLY collected and assembled the data. JCB, SMM, and KR analyzed the data. JCB, AOA, SMM, EP, and KR interpreted the data. SMM, KR, and PLY prepared the manuscript. All authors reviewed and revised the manuscript. All authors provided final approval of the manuscript.